Last CNY7.86 CNY
Change Today +0.01 / 0.13%
Volume 12.6M
As of 3:05 AM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

nanjing pharmaceutical co-a (600713) Snapshot

Open
CNY7.86
Previous Close
CNY7.85
Day High
CNY7.94
Day Low
CNY7.80
52 Week High
09/29/14 - CNY8.11
52 Week Low
10/8/13 - CNY4.80
Market Cap
5.5B
Average Volume 10 Days
24.0M
EPS TTM
CNY0.07
Shares Outstanding
693.6M
EX-Date
04/9/14
P/E TM
105.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for NANJING PHARMACEUTICAL CO-A (600713)

Related News

No related news articles were found.

nanjing pharmaceutical co-a (600713) Related Businessweek News

No Related Businessweek News Found

nanjing pharmaceutical co-a (600713) Details

Nanjing Pharmaceutical Co., Ltd. is primarily engaged in manufacture and distribution of Chinese medicines and western drugs in China. It is involved in the pharmaceutical distribution operations, which include operation of regular chain drug stores, delivery of pharmaceuticals, supply chain management, logistics services, and others; and pharmaceutical production operations providing Chinese patent medicines, tablets, capsules, granules, solvents, bulk drugs, and others. The company is also engaged in the asset management business, which includes credit guarantee and international trading, as well as provides hotel and information services. Nanjing Pharmaceutical Co., Ltd. was founded in 1951 and is based in Nanjing, the People’s Republic of China.

Founded in 1951

nanjing pharmaceutical co-a (600713) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nanjing pharmaceutical co-a (600713) Key Developments

NanJing Pharmaceutical Company Limited, Board Meeting, Aug 20, 2014

NanJing Pharmaceutical Company Limited, Board Meeting, Aug 20, 2014. Agenda: To approve the proposal of listing and transferring 49.67% equity of Nanjing Tongrentang (Huangshan) International Health Industry Management Co., Ltd.

NanJing Pharmaceutical Company Limited, Board Meeting, Aug 22, 2014

NanJing Pharmaceutical Company Limited, Board Meeting, Aug 22, 2014. Agenda: To approve the proposal of listing and transferring 49.67% equity of Nanjing Tongrentang (Huangshan) International Health Industry Management Co., Ltd.

Nanjing Pharmaceutical Company Limited Announces Earnings Results for the First Half of 2014

Nanjing Pharmaceutical Company Limited announced earnings results for the first half of 2014. For the period, the company reported basic earnings per share of CNY 0.037 and weighted average return on net assets of 2.53%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600713:CH CNY7.86 CNY +0.01

600713 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY59.90 CNY +0.55
Jointown Pharmaceutical Group Co Ltd CNY16.95 CNY +0.04
Shanghai Pharmaceuticals Holding Co Ltd CNY14.85 CNY +0.15
Wanjia Group Holdings Ltd $0.53 HKD -0.01
View Industry Companies
 

Industry Analysis

600713

Industry Average

Valuation 600713 Industry Range
Price/Earnings 100.0x
Price/Sales 0.3x
Price/Book 5.5x
Price/Cash Flow 121.1x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANJING PHARMACEUTICAL CO-A, please visit www.njyy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.